Module Test Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Define solubility

A

The maximum amount of solute that will dissolve in a given quantity of solvent at a given temperature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

State the three types of solvents

A
  • Polar solvents
  • Non-polar solvents
  • Semi-polar solvents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe what chemical features on a polar solvent increase solubility

A
  • Presence of polar groups
  • More branches
  • Ratio of polar groups to non-polar groups on molecule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the dielectric constant and state whether polar or non-polar solvents have a greater dielectric constant

A

The dielectric constant is the extent to which a material can store electrical charge.

Polar solvents have a higher dielectric constant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain hydrogen bonding

A

Interaction between a molecule containing a hydrogen atom and an electro-negative atom on the other molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Water is a polar solvent that is amphiprotic. Explain what this means.

A

Amphiprotic means that the solvent can act as a proton acceptor or donor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain Le Chatteliers principle of equilibrium

A

In an acid + water reaction, adding more acid will cause the equilibrium to shift towards reducing the amount of acid being produced

In an acid + water reaction, adding more base will cause the equilibrium to shift towards increasing the amount of acid produced (as the base reacts with H3O+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State the three types of ‘solutions’

A
  • Gas in liquid
  • Liquid in liquid
  • Solid in liquid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Temperature has an effect on the miscibility of liquid-liquid solutions. State and explain the 4 types of ‘critical’ temperatures,

A
  • Upper critical temperature (temperature @ full miscibility)
  • Lower critical temperature (temperature @ no miscibility)
  • Upper & lower critical temperature
  • No critical temperature (partial miscibility at all temperatures)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State the 4 solvation mechanisms

A
  • DIelectric constant
  • Dipole formation
  • Hydrogen bonding
  • Acid-base reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define ‘rheology’

A

The study of ‘flow’ and the deformation of matter.

Flow = The tendency of a material to deform following the application of force

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the resistance of flow in pharmaceutical applications

A

Water flows readily when poured = low resistance
- Good in certain medication for swallowing/digesting

Honey flows slowly when poured = high resistance
- Good for ointments and gels to stay on skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain newtonian flow

A

Shear stress increases in a linear fashion upon increasing shear rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain dilatant flow

A

Shear stress increases exponentially upon increasing the shear rate. This is because dilatant fluids are comprised of a high concentration of undissolved fluids. Therefore, when shear displaces the liquid, solid particles clump together and produce more resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain pseudo-plastic flow

A

Shear stress decreases the shear rate. This is because when pseudoplastic fluids are shaken or stirred, the bonds in the molecules are broken. As a result, viscosity decreases as ‘networks’ are broken.

Pseudoplastic fluids are capable of thixotropy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain thixotropy

A

The regain of structural integrity after shearing has stopped. Substances that have experience greater deformity will experience a slower rate of thixotropy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain Bingham plastics

A

Bingham plastics act as newtonian fluids (i.e. linear) beyond a certain yield stress. Therefore, before this yield stress, they are fairly solid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

State and explain how rheology affect pharmaceutic

A

Formulation stability: more viscous means slower sedimentation of undissolved particles

Biological activity: more viscous means slower movement of drug out of formulation

Patient acceptability: less viscous means easier to pour and swallow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain viscometry

A

The testing of viscosity. Machine involves immersing a spindle in fluid that can be rotated at different speeds to give a reading of viscosity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Define diffusion and explain its importance to pharmaceutics.

A

The net movement of molecules from a region of high concentration to a region of low concentration.

Important for drug movement and permeation around the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Diffusion is measured through quantifying molecular flux (f). State the components of molecular flux.

A

Mass (M) over cross sectional area of a barrier (S) and time (t).

Measures how many molecules are travelling through a cross-sectional area per second.

(Note: ‘S’ is the area of the ‘barrier’, NOT the ‘door’ meaning that a bigger barrier will mean a smaller door for the molecules to diffuse through meaning less molecules pass through per second meaning lower ‘f’)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Compare and contrast steady state and non-steady state diffusion.

A

Steady state diffusion is when the concentration gradient does not change over time. Non-steady state diffusion is when the concentration gradient changes over time, meaning that molecular flux will also change over time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the distribution of solutes in two immiscible liquids

A

If a solute is added to a mixture of two immiscible liquids, it will distribute itself amongst both phases. The solute will distribute more towards the liquid that is less dense and less polar.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

State the distribution law and the relevant assumptions made

A

Distribution law: concentration of X in A at equilibrium/concentration of X in B at equilibrium = partition coefficient

Assumptions: temperature remains constant, solute X is below saturation concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Discuss diffusion (ALL OF IT :L)

A
  • Lipophilicity and passive diffusion
    • Lipophilic molecules are better absorbed/diffuse through biological membranes
    • At a certain point, increasing lipid solubility will decrease drug activity due to:
      • Binding to lipids and only lipids
      • Won’t migrate towards site of action through fluids
  • Functions of biological membrane
    • Separate the aqueous contents of the cell from the external aqueous phase
    • Allow exchange of materials between inside and outside of a cell
    • As a result, biological membranes are lipid in nature, yet have selective permeability properties
  • Transport across biological membranes
    • Cross from one hydrophilic region to another through the lipophilic phospholipid membrane
      • Passive diffusion
        • Dependent on concentration gradient
        • Does not require energy
    • Or exploit carriers/aqueous pores in the membrane to get across:
      • Facilitated diffusion
        • Process involving a specialised carrier
        • No energy required
        • Dependent on concentration gradient
      • Active transport
        • Energy is required
        • Can go against concentration gradient
  • Factors affecting biological diffusion
    • Drugs are usually absorbed through passive diffusion
    • Which is affected by:
      • Lipophilicity of the drug
      • Water solubility of drug
      • Fraction of unionised form of drug
      • Microenvironments of the biological compartments and the membranes involved
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Compare and contrast LogP and LogD

A

LogP is the partition coefficient.
LogD is the distribution coefficient.

LogP is the equilibrium ratio of unionized drugs
LogD is the equilibrium ratio of un/ionized drugs

LogP remains constant
LogD changes with pH (fx degree of ionisation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Explain why the pH-partition hypothesis (and hence, LogD) cannot be applied to GI absorption

A

Variability in pH conditions.

pH at membrane surface is lower than that in the bulk

Convective flow refers to the movement of water into and out of the GI tract, which will affect the absorption rate of small molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Explain how ionised molecules can pass through the lipid membrane in the GI tract

A

The lipid membrane in the GI tract is negatively charged, meaning that it can attract cations (+) near the membrane. As a result, negatively charged molecules can pick up a cation or positively charged molecules can donate their positive charge to the membrane so that they can pass through.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Explain the difference between solubility and dissolution

A

Solubility is the extent to which a solute can dissolve in a solvent.

Dissolution is the rate at which a solute can dissolve in a solvent.

E.g. a drug can fully dissolve (high solubility) at a slow rate (low dissolution)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

State the 4 classes of drugs in the Biopharmaceutical Classification System

A

Class 1 - high permeability, high solubility
Class 2 - high permeability, low solubility
Class 3 - low permeability, high solubility
Class 4 - low permeability, low solubility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

State the properties required of a formulation to be eligible for a biowaiver and which class of drug is most likely to be eligible.

A

Rapid dissolution
High solubility
High permeability
Wide therapeutic window

Class I drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Explain what is meant by ‘sink conditions’

A

‘Sink condition’ is when the concentration of a drug/solute in the receptor region is significantly lower than in the donor region.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Explain why solute concentration in receptor region is not considered in the equation, J = DKC(d)/h

J = molecular flux
D = diffusion coefficient
K = partition coefficient
Cd = solute concentration in donor region
h = thickness of membrane
A

Because under ‘sink conditions’, ideally, the lowest possible solute concentration in the receptor region is approximately zero, meaning that it is negligible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Explain the difference between steady-state and non-steady-state diffusion

A

Steady-state diffusion follows Fick’s first law and assumes that the concentration gradient remains constant over time. Therefore, the rate of diffusion is dependent on the concentration gradient.

Non-steady-state diffusion follows Fick’s second law and states that the rate of diffusion is proportional to the rate of change of the concentration gradient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Describe what a biowaiver is and the properties that a formulation must possess to be eligible for a biowaiver.

A

A biowaiver is an exemption from conducting human bioequivalence studies.

Properties:

  • Rapid and similar dissolution
  • High solubility
  • High permeability
  • Wide therapeutic window
  • FDA approved “immediate release” excipients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is meant by a ‘dispersed system’? (provide 2 examples)

A

A system containing a dispersed phase (internal phase) and a continuous phase (dispersion medium).

Suspension - solid in liquid dispersion
Emulsion - liquid in liquid (immiscible) dispersion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

State the 3 classes of dispersion. Compare and contrast their properties.

A
  • Molecular (diffuses fast, invisible under an electron microscope, passes through ultrafilter)
  • Colloidal (diffuses slowly, visible under electron microscope but not light microscope)
  • Coarse (does not diffuse, visible under light microscope, does not pass through normal filter)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

A suspension is a coarse dispersion in which insoluble particles are dispersed in a liquid medium. Explain the applications of a suspension in terms of routes of administrations.

A

Oral route - can deliver water-insoluble drugs in an aqueous vehicle, taste masking, reduce hydrolysis

Topical route - slow drug release due to formulation needing to dissolve to produce an effect

Parenteral route - administer through IM or SC but not IV (due to risk of blocking vessels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Describe the disadvantages of suspensions

A
  • Sedimentation (caking)
  • Dose precision
  • Microbial contamination
  • Bulky packaging (bottles)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Describe the changes you can make to the formulation of a suspension to increase or prolong the rate of drug release.

A

Increase - in order to increase the rate of dissolution which results in high initial concentrations, the active component can be converted to a salt.

Prolong - to decrease the rate of dissolution and therefore have a prolonged release, the active component can be converted to a polymorph.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Describe the effect of wetting agents on suspensions

A

The high interfacial tension between the solid water-insoluble drug and the liquid medium may cause the solid drug molecules to clump up and aggregate in order to reduce the surface area exposed to the liquid.

Adding a wetting agent that decreases interfacial tension will prevent the drug molecules from aggregating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

In terms of particle size control, Stoke’s law states that the force required to move a sphere through a given viscous fluid is proportional to the velocity and radius of the sphere. State a limitation of this law.

A

Stoke’s law does not apply when there is an excessive amount of the suspended material due to collisions that influence the velocity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

State 3 advantages and 1 disadvantage of a smaller particle size

A

+ Slower rate of sedimentation
+ Less mechanical irritation
+ Ease of administration (no blocking of injection needle)

  • Does not allow slow drug release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Viscosity modifiers can be used to alter the physical properties of suspensions. State 4 physical properties of a well-formulated suspension.

A
  • Slow sedimentation
  • Easy re-dispersion
  • Homogenous
  • Easily transferable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Explain the ideal rheological properties in terms of standing, shaking and leaving with reference to viscosity

A

Standing - High apparent viscosity at low rates of shear so that on storage the suspended particles would either settle very slowly or preferably remain permanently suspended

Shaking - At moderate shear rates, the apparent viscosity should fall sufficiently to allow the suspension to be easily poured

Leaving - Original apparent viscosity should be regained after a relatively short time to maintain adequate levels of physical stability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Provide examples of viscosity modifiers

A
  • Polysaccharides
    • Acacia
    • Tragacath
    • Alginates
    • Starch
    • Xantham gum
  • Water-soluble celluloses
    • Methylcellulose
    • Hydroxy methylcellulose
  • Hydrated silicates
    • Bentonite
    • Magnesium aluminium silicate
    • Hectorite
  • Carbomers
    • Carboxy polymethylene
  • Colloidal silicon dioxide
    • Aerosil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Explain the difference between flocculated and deflocculated systems

A

Flocculated - loose sediments held together by weak van der Waals forces with a small amount of liquid medium in between, easily re-dispersible and fast sedimentation which can lead to inaccurate dosing

Deflocculated - a slower rate of sedimentation, therefore, more uniform dosing but prone to caking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Explain why flocculated particles sediment faster

A

Flocculated particles are particles that are loosely connected together. As a result, due to Stoke’s law, the particles are now ‘bigger’ which means that the velocity at which they sediment increases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Discuss how flocculation can be controlled using electrostatic stabilisation

A

Electrostatic stabilisation refers to the electrostatic charge of the particle surface and its ability to attract oppositely charged ions. Since particles of the same charge exert repulsive forces on each other, the attraction of these ions (and hence, the neutralisation of the particle) means that these repulsive forces are reduced. As a result, the particles are able to flocculate.

Electrolytes can be used to add ions to the suspension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Define ‘zeta potential’

A

Zeta potential is the potential difference between the dispersion medium and the stationary layer of fluid attached to the dispersed particle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Define an emulsion and state the two types

A

Two-phase systems in which one phase is dispersed as fine droplets into another phase.

Coarse emulsions and microemulsions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Explain the pharmaceutical relevance of emulsions

A

Emulsions allow us to entrap oil soluble drugs in dissolved form within an aqueous system and vice-versa.

Additionally, by designing a formulation that requires a drug to partition through different phases to reach its target, we can achieve sustained release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Explain why an emulsion may be appropriate for oral and topical route formulations

A

Oral route - easy to swallow (oily drug in aqueous medium), allows for taste masking

Topical route - can be made more viscous (ointments), pseudo-plastic properties for ease of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Describe the role of an emulsifier and provide examples

A

Emulsifiers coat the dispersed phase droplets to reduce the interfacial tension between the droplets with the medium.

Examples:

  • Surfactants
  • High molecular weight alcohols
  • Protein substances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

State and explain 4 processes that must be avoided for an emulsion to be stable with reference to reversibility and irreversibility.

A

Flocculation - droplets loosely aggregate into loose clusters (reversible with shaking)

Creaming - higher concentration of drug in one region leads to lack of uniformity in distribution (reversible with shaking)

Coalescence - dispersed droplets flow together to gain energy, surfactant layer in the interface is broken down (irreversible with shaking)

Breaking - phase separation (irreversible with shaking)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Explain how flocculation can be reduced in emulsions

A
  • Adding charged emulsifiers (cationic surfactant) but can be toxic
  • Adding electrolytes to reduce charge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Explain how creaming can be reduced in emulsions

A
  • Reduce droplet size
  • Increase viscosity
  • Reduce density difference between 2 phases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Explain how coalescence can be reduced in emulsions

A
  • Reduce interfacial tension by adding surfactant
  • Add mechanical barrier by adding hydrocolloid
  • Increase droplet charge to induce repulsion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Explain why microemulsions are more efficient than emulsions using Neoral and Sandimmune as examples.

A

Sandimmune is an o/w emulsion that requires further emulsification by bile salts and digestion by pancreatic enzymes prior to absorption.

Neoral is a preconcentrate that forms a homogenous microemulsion immediately on contact with GI fluids (i.e. less dependent on bile salts for absorption).

Neoral has a more consistent PK behaviour, less inter and intrapatient variation, and a more consistent bioavailability when administered with food.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Define ‘dosage form’ and provide a reason why biologically active entities are not usually administered as pure chemical substances.

A

Dosage forms are clinical packages in which a drug is presented to a patient.

Before biologically active entities are administered, we must consider patient acceptability, therapeutic issues, toxicity, stability, etc. As a result, we instead administer formulate preparations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

State the criteria that are considered when making a drug

A
  • Stability
  • Reliability
  • Convenience
  • Palatability
  • Effectiveness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Explain excipients

A

Chemical substances that aid in the formulation of a drug into the desired dosage form. Excipients are inner and physically and chemically stable.

Numerous functions include to solubilize, flavour, preserve, emulsify, suspend, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Explain the Pulsincap release

A

The Pulsincap delivery system is a time-dependent release formulation comprised of:

  • Enteric coat
  • Capsule cap
  • Hydrogel plus
  • Drug wafer
  • Ghost capsule body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Define bioavailability

A

The relative amount of an administered dose of a drug that reaches the systemic circulation unchanged.

The difference in bioavailability can vary with different routes of administrations, dosage forms or formulations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Define bioequivalence

A

The comparison of the bioavailability of a drug to a recognised standard dosage form. BE determines if the rate and extent of absorption are equivalent in test and standard drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Explain how particle size affects the effectiveness of a drug

A

Smaller particles have a greater surface area. As a result, they have increased contact with the dissolution medium and will dissolve faster, leading to greater absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Explain the Noyes-Whitney’s equation

A

dm/dt=kA(Cs-C)

dm/dt = the dissolution rate
k = dissolution rate constant
A = surface area of drug
Cs = solubility of the drug
C = concentration of solute in bulk solution at a time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Explain the common ion effect in relation to solubility

A

The common ion effect is the phenomenon whereby the addition of a common ion significantly reduces the solubility of a slightly soluble electrolyte (drug).

This is because when the common ion is added (e.g. by dissolving a salt), there is an increase in ‘products’ which causes the equilibrium to shift back towards the reactant (drug). It is important to note that this can only occur in slightly soluble systems due to the presence of an equilibrium.

69
Q

What is the rate-limiting step in the absorption process of poorly soluble drugs vs. freely soluble drugs

A

The rate-limiting step in poorly soluble drugs is disintegration. In freely soluble drugs, permeability is the rate-limiting step.

70
Q

Drugs can decompose as a result of heat, light, oxygen, moisture and pH changes. State the 4 classifications of drug stability.

A
  1. ) Stable under all conditions
  2. ) Stable if handled correctly
  3. ) Moderately stable even with special handling
  4. ) Very unstable
71
Q

State the advantages of oral route drug administration

A
  • Simple
  • Convenient
  • Safe
  • Local and systemic effects
72
Q

State the disadvantage of oral route drug administration

A
  • Must survive acidic conditions to be absorbed by GIT
  • Slow onset of action
  • Irregular absorption with food
73
Q

Briefly outline the anatomy of the GI tract

A

Oesophagus - links mouth and stomach, movement through swallowing

Stomach - temporary reservoir to deliver to the intestine, gastric secretions

Small intestine - capable of digestion and absorption, villi, duodenum, jejunum, ileum

Large intestine

74
Q

Define peptide drugs and protein drugs

A

Peptide drugs are drugs that have less than 50 amino acids

Protein drugs are drugs that have more than 50 amino acids

75
Q

Define transcellular and paracellular transport

A

Transcellular - across cells

Paracellular - between cells (particularly in the small intestine due to being ‘leaky’)

76
Q

Briefly describe the buccal route of drug administration

A

Drug administration through dissolution and diffusion in the oral cavity.

Treats local and systemic conditions and suitable for large, hydrophilic and unstable drugs.

77
Q

State the advantages of the buccal route of administration

A
  • Avoids the first-pass effect
  • Ease of administration and termination
  • Sustained release
  • Drug in a less hostile environment than GIT
78
Q

State the disadvantages of the buccal route of administration

A
  • Small absorption surface area (compared to GIT)
  • Oral cavity movement affects mucoadhesives
  • Less permeable (than small intestine)
  • Salivation and swallowing
  • Palatability needs to be considered
79
Q

State the advantages of the nasal route of administration

A
  • Avoids the first-pass effect
  • Rapid absorption
  • Low enzymatic levels mean easy saturation of drug
80
Q

State the disadvantages of the nasal route of administration

A
  • Low dose
  • Nasal irritation
  • Offensive odours
  • No toxic nasal metabolites
81
Q

State the advantages of the intravenous route of administration

A
  • Immediate access to the bloodstream
  • Maximum concentration reached rapidly
  • Large and small volumes can be given
  • Duration depends on the dose, ADME and the timescale of administration (single bolus vs. constant infusion)
82
Q

Explain the rate-limiting step of the intramuscular route of drug administration

A

IM is dependent on molecules being able to diffuse through the pores of capillary walls. Hence, transport through these capillary walls is the rate-limiting step

83
Q

Provide a reason why subcutaneous injection occurs slower than intramuscular injection

A

Dissolution and absorption occur slower in SC because the blood supply is not as good as it is in IM

84
Q

Briefly describe intrathecal drug administration

A

A method of delivering drugs to the brain and spinal cord via injection into the spinal canal.

Generally more ‘invasive’ than IV, IM and SC.

85
Q

Rectal drug delivery can often be used in place of PO. Provide advantages and disadvantages of rectal drug delivery.

A

+ Avoids the first-pass effect
+ Local and systemic

  • Slow and incomplete absorption
  • Significant inter/intra-subject variation
86
Q

Describe how rectal drug delivery occurs

A

Suppository dissolves in rectal fluid or melts on the mucous layer (depending on vehicle). Drug molecules will then enter general circulation (avoid first-pass) or via the liver.

87
Q

Briefly discuss vaginal drug delivery

A

Generally used for local effects but the wide network of blood vessels in the vagina can allow for systemic effects. Drug adheres to mucosal layer in vagina and dissolves. Absorption tends to vary.

88
Q

State the advantages of pulmonary drug delivery

A
  • Direct administration to site of action (lungs)

- Rapid onset of action

89
Q

State the disadvantages of pulmonary drug delivery

A
  • Seeks to defeat the body’s natural defences
  • Demanding on patient
  • Patient variability
  • Specific particle size necessary for the absorption
90
Q

Recommend methods of masking the taste of orally administrated drugs

A
  • Coating tablets
  • Using capsules
  • Making emulsions/suspensions
91
Q

Define preformulation

A

A branch of pharmaceutical science that utilizes biopharmaceutical principles in the determination of physicochemical properties of drug properties

92
Q

Describe why preformulation is significant to drug delivery and formulation development

A

Drug delivery - new chemical entities (NCE) should possess optical biopharmaceutical properties to become drugs.

Formulation development - physicochemical properties must be studied, dictates possible approaches to formulation development and helps understand events and mechanisms of a drug at different stages.

93
Q

Describe the importance of the analytical method of fundamental preformulation parameters

A

To determine the amount of the compound of interest is present since impurities can be present too. This is done by UV-Vis and HPLC.

94
Q

Describe intrinsic solubility

A

Refers to the solubility of the drug in an unionised form. Drugs in unionised form are more lipophilic and easily absorbed.

95
Q

Explain LogP and how we can distinguish lipophilicity and hydrophilicity with the LogP value

A

Measure of the relative solubility of drug in solvents compared with its solubility in water.

LogP > 1 - Lipophilic
LogP < 1 - Hydrophilic

96
Q

Explain polymorphism

A

Polymorphs relates to solid material with at least two different molecular arrangements which give distinct crystal species

Polymorphs markedly differ in their physical, chemical and optical properties due to different crystalline structures

Highest melting species are usually most stable (form 1), others (form 2, 3, etc.) are metastable and have a tendency to convert to the stable form

97
Q

State the 7 Fundamental Preformulation Parameters

A
  • Analytical method
  • Solubility
  • Salts
  • Partition Coefficient
  • Melting Point
  • Polymorphism
  • Stability
98
Q

State the 4 Derived Preformulation Parameters

A
  • Microscopy
  • Particle size analysis
  • Bulk density
  • Flow properties
  • Excipient compatibility
99
Q

Explain why particle size analysis is important

A

Particle size can influence dissolution rate, uniform distribution, penetrability and suspendability.

100
Q

State 5 methods of particle size determination

A
  • Sieving
  • Optical microscope
  • Sedimentation
  • Coulter counter
  • Laser diffraction
101
Q

Explain Differential Scanning Calorimetry

A

DSC is a method of measuring excipient compatibility.

Comprises of comparing the DSC interactions between a sample of the drug and a sample of a 50:50 drug-excipient mixture.

Interaction example: melting point.

102
Q

Define bioavailability

A

Extent and rate at which a substance or its active moiety is delivered from a pharmaceutical form and becomes available in the general circulation.

103
Q

Compare and contrast absolute BA and relative BA

A

Absolute - comparison of the bioavailability of a particular dosage form with that following IV administration (100%).

F = (AUCev/AUCiv) x (DoseIV/DoseEV)

Relative - comparison of AUC value of different dosage forms.

F = (AUCev1/AUCev1) x (DoseEV2/DoseEV1)

104
Q

State and explain the two parameters of measuring BA

A

Extent of absorption - the fraction of the dose which enters systemic circulation

Rate of absorption - the time delay between the administration of the drug and the time of maximum concentration in the plasma.

105
Q

State factors that affect BA and provide methods to avoid variation when testing for BA

A

Factors:

  • Body weight
  • Sex and age
  • Disease
  • Genetics

How to avoid:

  • Choose subjects with similar ranges
  • Specify ranges to maintain consistency
106
Q

Compare and contrast brand-name drugs and generic drugs

A

Brand-name drug:

  • Supplied by one drug company
  • Sold under drug company’s trademarked name

Generic drug

  • May be supplied by more than one company
  • May be sold under different names
  • Lower cost version of the brand name drug
107
Q

Explain patent protection

A

Patent protection protects the investment of the drug company that developed the drug by giving sole rights to that company to sell that drug while the patent is in effect.

108
Q

Define pharmaceutical equivalence

A

Drugs are considered pharmaceutical equivalents if they contain the same active ingredients, the same dosage form, route of administration and are identical in strength and concentration.

But they may differ in characteristics such as shape, scoring configuration, release mechanisms, packaging, excipients (inc. colours, flavours, preservatives) and, within certain limits, labelling

109
Q

Define therapeutic equivalence

A

Drug products are considered to be therapeutic equivalents only if they are pharmaceuticals equivalents and if they can be expected to have the same clinical effect and safety profile when administered to patients under the conditions specified in the labelling

110
Q

Define pharmaceutical alternatives

A

Drug products are considered pharmaceutical alternatives if they contain the same therapeutic moiety, but are different salts, esters, or complexes of that moiety or are different dosage forms

111
Q

Define bioequivalence

A

The absence of significance difference in the rate and extent to which an active ingredient or active moiety in pharmaceutical equivalence or pharmaceutical alternative becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.

112
Q

Describe how two products can be considered interchangeable

A

When they are pharmaceutically equivalent.

When their BA after administration in the same dose are similar to a degree where efficacy and safety are the same.

113
Q

State the attributes that make two products non-interchangeable

A
  • Product has a narrow therapeutic index
  • Product delivery systems are not pharmaceutically equivalent
  • No acceptable method to establish BE (e.g. topical products - since every individual’s skin is different and will respond differently)
114
Q

State the 3 properties of small particles

A
  • Particle size
  • Particle shape
  • Particle surface area
115
Q

Describe what is meant by a ‘hypothetical sphere’

A

In order to measure the diameters of irregular (non-spherical) particles, we approximate a ‘hypothetical sphere’ for such particles. This ensures that we can as accurately as possible measure its size. Hypothetical spheres can be determined using length, weight, volume, surface area, etc.

116
Q

Explain the difference between Martin’s diameter and Feret’s diameter

A

Martin’s diameter -distance between opposite sides of a particle on a line bisecting the projected area.

Feret’s diameter - distance between parallel tangents on opposite sides of the particle profile.

117
Q

Define the projected area diameter

A

The diameter of a circle with the same area as that of the particle.

118
Q

Define the projected perimeter diameter

A

The diameter of a circle having the same perimeter of the particle.

119
Q

State the disadvantages of microscopy

A
  • Only 2-D
  • Tedious
  • Eye strain
  • Operator error
120
Q

State the 6 methods of determining particle size

A
  • Microscopy
  • Sieving
  • Coulter counter
  • Laser light scattering
  • Photon correlation spectroscopy
  • Sedimentation
121
Q

Explain sieving

A

Sieving is a method of determining particle size by having particles pass through multiple sieves of different diameters.

The particles ability to pass through depending on size, orientation and shape.

122
Q

State the disadvantages of sieving

A
  • Small amount of sample

- Difficulty sieving oily or cohesive powders/granules due to clogging

123
Q

Explain the Coulter Counter method of particle size determination

A

The powdered substance is dispersed in electrolyte liquid. Particles passes between two electrodes which monitor the change in electrical signal when the particle occupies orifice and displaces a volume of electrolytes equal to its own.

Change in resistance is proportional to volume. Resistance is converted into a voltage pulse which is amplified and processed electronically.

124
Q

State the practical considerations when using the Coulter Counter method

A
  • Tube selection
  • Electrolyte (must conduct electricity but not dissolve particles)
  • Dispersion (need suitable concentration, break aggregates, representative sample)
  • Coincidence (changes of more than one particle at a time < 10%)
125
Q

State the two types of light scattering techniques used for particle size determination and determine under what conditions would you use one over the other.

A
  • Laser diffraction (particle diameter 1-1000 um)

- Photon correlation spectroscopy (particle diameter 0.001-1 um)

126
Q

Explain the lase diffraction method of particle size determination

A

Observes the interaction between particles and the wavelength of light. Larger sized particles diffract light in irregular patterns to a lesser degree. Smaller sized particles diffract light in irregular patterns to a greater degree.

127
Q

State and explain the two theories that laser diffraction is based on

A

Fraunhofer theory - light interactions with particles causes light to be scattered in a forward direction with only a small change in angle.

Mie scatter theory - agrees with Fraunhofer, but also accounts for some side scatter of light. Therefore, considers optical properties of particles (i.e. refractive index)

128
Q

Explain the Photo Correlation Spectroscopy method of particle size determination

A

Based on the Brownian motion (random movement of particles due to collision), PCS analyses the constantly changing patters of laser light scattered or diffracted by particles that produce a flicker. The smaller the particle, the higher the rate of flicker.

129
Q

Explain the Sedimentation method of particle size determination

A

Measurement of particle size through observing particle’s free falling velocity.

Follows Stoke’s law which assumes smooth, rigid sphere, no particle interactions and aggregation.

130
Q

Define porosity and state the associated equation

A

Porosity is the measure of void spaces in materials.

(Vb-Vp)/Vb

Vb = bulk volume
Vp = true volume
131
Q

State the 6 derived properties of powders

A
  • Porosity
  • Packing arrangements
  • Density
  • Flow properties
  • Dissolution
  • Compaction
132
Q

State the two ideal packing arrangements

A
  • Rhombohedral (3 particles)

- Cubic (4 particles)

133
Q

State the three types of densities

A
  • True density (excluding all voids)
  • Granule density (determine by mercury displacement
  • Bulk density (determine by bulk volume and weight)
134
Q

Explain the significance of flow properties

A

Powders need to flow well for a uniform distribution, and consistent drug amounts in each tablet.

135
Q

Describe the method used to measure flow properties

A

Angle of repose - the maximum angle that can be obtained between the free-standing surface of a powder heal and the horizontal plane.

Based on the particles cohesive vs. adhesive properties.

Greater angles of repose indicate poor flow.

136
Q

Describe the factors influencing flow properties

A

Particle size - fine particles with high surface area are more cohesive

Particle size distribution - reducing fine particles and increasing large particles (granulation)

Particle shape and texture - spherical particles have better flow

Moisture content - moisture impairs flowability, powders should be dried

137
Q

Define compactibility

A

A powders tendency/ability to form a coherent tablet. Powders with high compatibility can form tablets with high resistance against capping and lamination.

Granules have better compactibility than powders.

138
Q

State 5 methods of stabilising an emulsion

A
  • Change particle size
  • Change viscosity
  • Introduce a surfactant
  • Introduce a mechanical barrier
  • Increase charge
139
Q

State 5 factors affecting dissolution rate

A
  • DIffusion coefficient of the solution (viscosity, temperature, solvent)
  • Surface area of solid
  • Solubility of solid
  • Concentration of solute in the bulk
  • Thickness of diffusion layer
140
Q

Define a solution

A

A homogenous mixture of two or more components.

141
Q

State and define the two types of solutions

A

Non-electrolyte - substances that do not ionise in water

Electrolyte - substances that ionise in water (strong electrolytes completely ionise in water, weak electrolytes incompletely ionise in water)

142
Q

State the conditions of an ideal solution

A
  • No change in properties of the components other than dilution
  • No heat is evolved or absorbed during the mixing process
  • No expansion or shrinkage

Non-ideal solutions are solutions where the mixing of components is associated with the evolution of heat or some other change (other than dilution)

143
Q

Under what conditions would you expect positive and negative deviations from Raoult’s law?

A

Adhesive < Cohesive = vapour pressure is greater than expected from Raoult’s law

Adhesive > Cohesive = vapour pressure is less than expected from Raoult’s law

144
Q

State the 4 colligative properties

A
  • Lowering vapour pressure
  • Boiling point elevation
  • Freezing point depression
  • Increasing osmotic pressure
145
Q

State advantages and disadvantages of solutions

A

+ Easy to swallow
+ Homogenous mixture
+ Flexible dosing
+ Various RoA

  • Bulky packaging
  • Low shelf-life
  • Microbial growth
146
Q

Define complexes

A

Compounds result from Lewis acid-base reactions between two or more chemical constituents results in a covalent bond - sharing of electrons.

Complexes are composed of two. or more molecules or ions held together in a unique structural relationship.

147
Q

State the 3 types of complexes

A
  • Inclusion complex
  • Metal ion complex
  • Organic molecular complex
148
Q

Inclusion complexes involve a constituent being trapped in a cage-like crystal structure of the other. State the 4 types of inclusion complexes.

A
  • Channel lattice type
  • Layer type
  • Clathrates
  • Cyclodextrin inclusion
149
Q

Explain the channel lattice type of inclusion complexes

A

Inclusion complexes whereby compounds crystallize in a channel-like structure permitting enclosure of non-branched compounds.

Example: urea

150
Q

Explain the layer type of inclusion complexes

A

Inclusion complex whereby compounds are trapped in clay minerals.

151
Q

Explain the channel lattice type of inclusion complexes

A

Inclusion complexes whereby compounds crystallise in the form of cage-like lattices in which guest molecules can be trapped.

Dependent on the molecular size of the guest molecule.

152
Q

Explain the monomolecular type of inclusion complexes

A

Monomolecular complexes involve the entrapment of a single guest molecule in the cavity of a host molecule.

Example: cyclodextrin

153
Q

Explain the structure of cyclodextrins

A

Cyclodextrins are cylindrical rings with a large interior cavity that can hold guest molecules. The inner layer (cavity) is hydrophobic whereas the outer layer is hydrophilic. This allows the complex to hold hydrophobic guest molecules of the appropriate size.

Example: Piroxicam, mitomycin C

154
Q

State the applications of cyclodextrin

A
  • Solubility enhancement
  • Taste masking
  • Stabilizer and protector
  • Dissolution enhancement
155
Q

Explain metal ion complexes

A

Type of inclusion complex whereby ligands donate a pair of electrons to metal ions (acceptors) forming a complex.

156
Q

Explain chelates, a subtype of metal ion complexes

A

An organic substance containing two or more donor groups combining with metal to form a special complex.

157
Q

State the applications of chelates

A
  • Heavy metal detoxification
  • Drug stabilisation
  • Pharmaceutical assays
158
Q

State the two types of organic molecular complexes

A

Polymer complex - modify biopharmaceutical parameters of the drug (e.g. reduce staining and irritation)

Drug complex - improves drug release and absorption

159
Q

Explain the Basket Assembly dissolution apparatus

A

Tablet is placed in a rotating basket within a vessel and samples of the liquid it is immersed in are taken at different time intervals to measure dissolution.

160
Q

Explain the Paddle method dissolution apparatus

A

Tablet is placed at the bottom of a vessel below a rotating paddle. Likewise, with the Basket Assembly method, a sample of the liquid within the vessel is taken at different time intervals to measure the level of dissolution.

161
Q

State 4 techniques used to modify drug release

A
  • Enteric coating
  • Matrix
  • Bioadhesive
  • Ion-exchange resins
162
Q

Explain enteric coating in terms of modified drug release

A
  • Can protect the drug from harsh gastric environment
  • Can protect stomach lining from irritation from drug
  • Can allow drug to dissolve at certain regions of the GIT
163
Q

Explain bioadhesive polymers in terms of modified drug release

A

The coating on the delivery system binds to biological surfaces (mucoadhesion). This allows for increased contact time with the target tissue for sustained release.

164
Q

Explain polymer matrices in terms of modified drug release

A

The process involves fluid penetrating matrix and reaching drug, fluid dissolving drug and the drug leeching out. These steps allow for prolonged release.

165
Q

State and explain the two types of polymer matrices

A

Non-erodible - drugs molecules near the surface of the matrix are dissolved first meaning high initial concentration. However, since non-erodible matrix, fluid is required to travel deeper to reach drug molecules near the centre of the formulation. As a result, prolonged release and inconsistent concentration.

Erodible - fluid dissolves drug molecules and polymer matrix meaning that drug molecules near the centre become more exposed.

166
Q

Explain the concept of an osmotic pump

A

Osmotic pumps involve the drug, a semi-permeable membrane, osmogens and a delivery orifice.

The semi-permeable membrane allows water to enter and come into contact with the osmogen. This causes the osmogen to expand and ‘push out’ the drug through the delivery orifice. The orifice is the only way the drug can be released which allows for a controlled release.

167
Q

Explain ion-exchange resins

A

Ion-exchange resins are used for cationic and anionic drugs whereby a resin bead is attached to a drug to neutralise it. The drug is released when it comes into contact with biological fluid where it will detach from the resin.

168
Q

State the assumptions made by the Higuchi equation

A
  • Initial drug concentration in the matrix is higher than drug solubility
  • Diffusion takes place in one dimension
  • Matrix does not erode
  • Drug diffusion is constant
  • Perfect sink conditions
169
Q

Describe the differences in the appearance of a Fickian line vs. a Case II line in the Korsmeyer-Peppas graph and explain what they mean

A

Fickian - line is slightly curved indicating that there is an initial high concentration which eventually slows down. This shows that a non-erodible matrix is used as the presence of a depletion zone reduced the rate at which the drug molecules at the centre reach the fluid and dissolve.

Super Case II - linear drug release over time showing an erodible matrix that lacks a depletion zone, therefore, drug molecules both near the surface and at the centre are exposed to the fluid at an equal rate as the tablet degrades.